Alopecia Areata Trial Results, Skin Oncology Top EADV Agenda Alopecia Areata Trial Results, Skin Oncology Top EADV Agenda
Early results from a trial of JAK inhibitors for hair loss will be unveiled at the upcoming dermatology meeting. Specialists will also delve into the adverse skin effects of immunotherapy.Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Dermatology News Source Type: news
More News: Alopecia | Alopecia Areata | Cancer & Oncology | Dermatology | Health | Immunotherapy | Skin